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Abstract
Technological advances are enabling us to collect multiple types of data at an increasing
depth and resolution while decreasing the labor needed to compile and analyze it. A central
goal of multimodal data integration is to understand the interaction effects of different features.
Understanding the complex interaction among multimodal datasets, however, is challenging. In
this study, we tested the interaction effect of multimodal datasets using a novel method called
the kernel method for detecting higher order interactions among biologically relevant mulit-
view data. Using a semiparametric method on a reproducing kernel Hilbert space (RKHS),
we used a standard mixed-effects linear model and derived a score-based variance component
statistic that tests for higher order interactions between multi-view data. The proposed method
offers an intangible framework for the identification of higher order interaction effects (e.g.,
three way interaction) between genetics, brain imaging, and epigenetic data. Extensive numeri-
cal simulation studies were first conducted to evaluate the performance of this method. Finally,
this method was evaluated using data from the Mind Clinical Imaging Consortium (MCIC) in-
cluding single nucleotide polymorphism (SNP) data, functional magnetic resonance imaging
(fMRI) scans, and deoxyribonucleic acid (DNA) methylation data, respectfully, in schizophre-
nia patients and healthy controls. We treated each gene-derived SNPs, region of interest (ROI)
and gene-derivedDNAmethylation as a single testing unit, which are combined into triplets for
evaluation. In addition, cardiovascular disease risk factors such as age, gender, and body mass
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index were assessed as covariates on hippocampal volume and compared between triplets. Our
method identified 13-triplets (p-values ≤ 0.001) that included 6 gene-derived SNPs, 10 ROIs,
and 6 gene-derived DNA methylations that correlated with changes in hippocampal volume,
suggesting that these triplets may be important in explaining schizophrenia-related neurode-
generation. With strong evidence (p-values ≤ 0.000001), the triplet (MAGI2, CRBLCrus1.L,
FBXO28) has the potential to distinguish schizophrenia patients from the healthy control vari-
ations. This novel method may shed light on other disease processes in the same manner, which
may benefit from this type of multimodal analysis.
keywords: Multimodal data, Higher order interaction, Kernel methods, Imaging genetics, Imaging
epigenetics, and Schizophrenia.
1 Introduction
The advancements in data science technology over the last decade has rapidly evolved to collect
multi-view data, which has emerged to provide a comprehensive way to explore statistical structures
and information embedded in the relationship between datasets. The integration of imaging and
genetic information into a format capable of predicting disease phenotypes, however, continues to
be challenging problem.
One of the goals of imaging genetics is the modeling and understanding of how genetic varia-
tions influence the structure and function of brain disease. This goal can be achieved by collating
multimodal data including functional magnetic resonance imaging (fMRI), structural MRI (sMRI),
and positron emission tomography (PET) scans with single nucleotide polymorphisms (SNPs), de-
oxyribonucleic acid (DNA) methylations, gene expression (GE), transcriptomics, epigenomics, and
proteomics factors. Numerous studies have suggested that these different factors do not act in isola-
tion, but rather they interact at multiple levels and depend on one another in an intertwined manner
(Calhoun & Sui, 2016; Pearlson, Liu, & Calhoun, 2015). Extracting the interaction effects from
within and among data sets, however, remains a challenge for multi-view data analysis (J. Li et al.,
2015; Chekouo, Stingo, Guindani, & Do, 2016; Zheng, Cai, Ding, Nie, & Hung, 2015; Zhao, Qiao,
F. Shi, & Shen, 2016; M. Liu, Min, Y. Gao, & Shen, 2016). Figure 1 illustrates how the interaction
effects of different data sets can be used to model and predict human illness.
To date, both genetic techniques and brain imaging have played a substantial role in detecting
disease phenotypes. For example, by correlating imaging and genetic data, it has been shown that
certain genes affect specific brain functions, connectivity, and serve as risk predictors for certain
diseases. (Jahanshad et al., 2012; Lin, Callhoun, & Wang, 2014; Bis, DeCarli, & et al., 2012; Ja-
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Figure 1: An illustration of the different imaging genetics and epigenetics data along with their
interaction effect on human behavior. Note, SNP: single nucleotide polymorphism, DNA: deoxyri-
bonucleic acid methylations, PET: positron emission tomography (PET), fMRI: functional magnetic
resonance imaging (fMRI), sMRI: structural MRI, GE: gene expression.
hanshad & X. Hua, 2013). Additionally, (Bis et al., 2012) have identified genetic variants affecting
the volume of the hippocampus, which could be used as predictors of cognitive decline and de-
mentia (Jahanshad & X. Hua, 2013). As shown in (Wen et al., 2017), accurate identification of
Tourette’s syndrome in children has notably improved using multi-view features as compared to
relying solely on one view. Accumulating evidence also shows that the inherent genetic variations
for complex traits can sometimes be explained by the joint analysis of multiple genetic features with
environmental factors.
Schizophrenia (SZ) is a complex brain disorder that affects how a person thinks, feels and acts,
which is thought to be caused through an interplay of genetic effects, brain region, and DNAmethy-
lation abnormalities (Richfield, Alam, Calhoun, & Wang, 2017). Studies using neurological tests
and brain imaging technologies (fMRI and PET) have been used to examine functional differences
in brain activity that seem to arise within the frontal lobes, hippocampus and temporal lobes (Van
& Kapur, 2009; Kircher & Renate, 2005). Many researchers have shown that genetic alterations at
the mRNA and SNP level, however, also play a significant role in SZ (Chang, Kruger, Kustra, &
Zhang, 2013; Lencz et al., 2007). Thus, only focusing on brain imaging data is not sufficient in the
identification of the related risk factors for SZ (Potkin, T. G. M. Van, Ling, Macciardi, & Xie, 2015).
To address this, (Chekouo et al., 2016) have developed the ROI-SNP network for the selection of
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discriminatory markers using brain imaging and genetics information.
A number of studies suggest that epigenetics also has a role in SZ disease susceptibility. Genome-
wide DNA methylation analysis of human brain tissue from SZ patients shows a heritable epige-
netic modification, which can regulate gene expression. The cell specific differences in chromatin
structure that influence cell development, including DNA methylation, have emerged as a potential
explanation for the non-Mendelian inheritance of SZ (Wockner et al., 2014). There is also evidence
on epigenetic alterations in the blood and central nervous system of patients with SZ, and it has
been shown that methylation status in brain tissue from SZ patients varies significantly from con-
trols (Aberg, McClay, Nerella, & et al., 2014; Montano, Tauband, Jaffe, Briem, & et al., 2016). In
this paper, we consider the interaction effects among the genetics, brain imaging, and epigenetics
data on hippocampal volume measurements between SZ patients and healthy controls using a novel
kernel method for detecting these higher order interactions.
Many advancements in multimodal fusion methods have utilized such approaches as co-training,
multi-view learning, subspace learning, multi-view embedding, and kernel multiple learning, to an-
alyze multi-view data of biological relevance (Xu, Tao, & Xu, 2013). However, due to the large
number of genes, SNPs, DNA methylations and different types of imaging, positive definite kernel
based methods have become a popular and effective tool for conducting genome-wide association
studies (GWASs) and imaging genetics, especially for identifying genes associated with diseases
(S. Li & Cui, 2012; Ge et al., 2015; Alam, Calhoun, & Wang, 2016; Alam, Komori, Calhoun, &
Wang, 2016). Kernel methods are emerging as innovative techniques that map data from high di-
mension input spaces to a kernel feature space using a nonlinear function. The main advantage of
these methods is to combine statistics and geometry in an effective way (Hofmann, Scho¨lkopf, &
Smola, 2008). Kernel methods offer useful algorithms to learn how a large number of genetic vari-
ants are associated with complex phenotypes, to help explore the relationship between the genetic
markers and the outcome of interest (Camps-Valls, Rojo-Alvarex, & Martinez-Romon, 2007; S. Yu
&Moreau, 2011; Alam, 2014; Alam & Fukumizu, 2015; Scho¨lkopf, Smola, & Mu¨ller, 1998; Kung,
2014).
In genetics, the detection of gene-gene interactions or co-associations in most methods are di-
vided into two types: SNP based and gene-based methods in GWASs. In the last decade, a number
of statistical methods have been used to detect gene-gene interactions (GGIs). Logistic regression,
multifactor dimensionality reduction, linkage disequilibrium and entropy based statistics are exam-
ples of such methods (Hieke, Binder, Nieters, & Schumacher, 2014; Wan et al., 2010). While most
of these methods are based on the unit association of the SNPs, testing the associations between
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the phenotype and SNPs has limitations and is not sufficient for interpretation of GGIs (Yuan et al.,
2012). In GWASs, gene-based methods are always more effective than the ones based only on a
SNP, and powerful tools for multivariate gene-based genome-wide associations have been proposed
(Sluis et al., 2015).
In recent years, linear, kernel, and robust canonical correlation based U statistic have been
utilized to identify gene-gene co-associations (Peng, Zhao, & Xue, 2010; Alam, Komori, et al.,
2016). (S. Li & Cui, 2012) have proposed a model-based kernel machine method for GGIs. In
addition, (Ge et al., 2015) have also proposed a kernel machine method for detecting effects of
interactions between multi-variable sets. This is an extended model of (S. Li & Cui, 2012) to jointly
model the genetics and non-genetic features, and their interactions. While these methods could
ultimately shed light on novel features of the etiology of complex diseases, they cannot be reliable
used in multi-view data sets. Thus, there exists a need to extend kernel machine based methods.
The contribution of this paper, therefore, is threefold. By examining the three-way interaction
effects between triplet data sets combining genetics, imaging, and epigenetics, we hope to shed light
on the phenotype features associated with disease mechanisms. This is done iteratively. First, we
propose a novel semiparametric method on a reproducing kernel Hilbert space (RKHS) to study
the interaction effects among the multiple-view datasets. We name a kernel method for detecting
higher order interactions (KMDHOI) and include the pairwise and higher order Hadamard product
of the features from different views. Second, we formulate the problem as a standard mixed-effect
linear model to derive a score-based variance component test for the higher order interactions. The
proposed method offers a flexible framework to account for the main (single), pairwise, triplet, other
higher order effects and test for the overall higher order effects. Finally, we validate the proposed
method on both simulation and the Mind Clinical Imaging Consortium (MCIC) data (J. Chen et al.,
2012; Gollub et al., 2013).
The remainder of this paper is organized as follows. In Section 2, we propose a standard mixed-
effects linear model to derive score-based variance component test for higher order interaction. In
Section 3, we propose statistical testing for higher order interaction effects. The relevant methods are
discussed in Section 4. In Section 5, we describe the experiments conducted on both synthesized and
the imaging genetics data sets. We conclude the paper with a discussion of major findings and future
research in Section 6. Details of the theoretical analysis for the proposed method, Satterthwaite
approximation to the score test, and supplementary tables and figures on application to imaging
genetics and epigenetics can be found in the appendix.
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2 Method
In kernel methods, the nonlinear feature map is given by a positive definite kernel, which provides
nonlinear methods for data analysis. It is known (Aronszajn, 1950) that a positive definite kernel k
is associated with a Hilbert spaceH , called reproducing kernel Hilbert space (RKHS), consisting
of functions on X so that the function value is reproduced by the kernel; namely, for any function
f ∈ H and a point X ∈ X, the function value f (X) is f (X) = 〈 f (·), k(·, X)〉H , where 〈, 〉H in
the inner product ofH is called the reproducing property. Replacing f with k(·, X˜) yields k(X, X˜) =
〈k(·, X), k(·, X˜)〉H for any X, X˜ ∈ X. A symmetric kernel k(·, ·) defined on a space X is called positive
definite, if for an arbitrary number of points X1, . . . , Xn ∈ X the Gram matrix (k(Xi, Y j))i j is positive
semi-definite. To transform data for extracting nonlinear features, the mapping Φ : X → H is
defined as Φ(X) = k(·, X), which is a function of the first argument. This map is called the feature
map, and the vector Φ(X) in H is called the feature vector. The inner product of two feature
vectors is then 〈Φ(X),Φ(X˜)〉H = k(X, X˜). This is known as the kernel trick. By this trick the kernel
can evaluate the inner product of any two feature vectors efficiently without knowing an explicit
form of Φ(·).
2.1 Model setting
Assuming that we have n independent identical distributed (IID) subjects yi (i = 1, 2, · · · , n) with
(q − 1) covariates Xi = [Xi1, Xi2 · · · Xi(q−1)]T and m-view datasets, M(1)i , · · · ,M(m)i . In the following
semiparametric model, we associate the output yi with covariates including intercept and m-view
datasets:
yi = X
T
i β + f (M
(1)
i
, · · · ,M(m)
i
) + ǫi, (1)
where Xi is a q × 1 vector of covariates including intercept for the i−th subject, β is a q × 1 vector
of fixed effects, f is an unknown function on the product domain, M =M(1) ⊗M(2)⊗, · · · ,⊗M(m)
withM
(ℓ)
i
∈ Mℓ, ℓ = 1, 2, · · ·m and the error ǫi’s are IID as normal with mean zero and variance σ2,
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ǫi ∼ NIID(0, σ2). According to the ANOVA decomposition, the function, f can be extended as:
f (M
(1)
i
, · · · ,M(m)
i
) =
m∑
ℓ=1
hM(ℓ)(M
(ℓ)
i
) +
∑
ℓ1>ℓ2
hM(ℓ1),M(ℓ2)(M
(ℓ1)
i
,M
(ℓ2)
i
)+
∑
ℓ1>ℓ2>ℓ3
hM(ℓ1)×M(ℓ2)×M(ℓ3)(M
(ℓ1)
i
,M
(ℓ2)
i
,M
(ℓ3)
i
)+· · ·+hM(1)×M(2)×M(3)×··· ,×M(m)(M(1)i ,M(2)i , · · · ,M(m)i ),
(2)
where hM(ℓ)(Mi
(ℓ))’s (ℓ : 1, 2, · · ·m) are the main effects for the respective dataset, hM(ℓ1),M(ℓ2)(M(ℓ1)i ,M(ℓ2)i )
are pairwise interactions effects, hM(ℓ1)×M(ℓ2),M(ℓ3)(M
(ℓ1)
i
,M
(ℓ2)
i
,M
(ℓ3)
i
) are the interactions effects of
the three dataset and so on. The functional space, RKHS, is decomposes as:
H = HM(1) ⊕HM(2) ⊕ · · · ⊕ HM(m) ⊕HM(1)×M(2) ⊕HM(1)×M(3) ⊕ · · · ⊕ HM(1)×M(m) ⊕HM(2)×M(3)
⊕ · · · ⊕ HM(1)×M(2)×M(3) ⊕ · · · ⊕ HM(1)×M(2)×···×M(m) , (3)
equipped with an inner product, 〈·, ·〉 and a norm ‖ · ‖H . If m = 1, Eq. (1) becomes simple semipara-
metric regression model as shown in (D. Liu, Lin, & Ghosh, 2007). (S. Li & Cui, 2012) and (Ge et
al., 2015) have proposed similar models (special case of Eq. (1), m = 2) for detecting interaction
effects among multidimensional variable sets.
Specifically, in our case we have three data sets. To do this, we assume that we have n IID
subjects under investigation; yi (i = 1, 2, · · · n) is a quantitative phenotype for the i-th subject (say,
hippocampal volume derived from structural MRI scan). We associate the clinical covariates (e.g.,
age, weight, height) with three views: genetics, imaging, and epigentics (gene-derived SNP, ROIs,
and gene-derived DNAmethylation). LetXi denote the (q−1) covariates, where Xi j, j = 1, 2, · · · (q−
1) is a measure of the i-th subject. Let M
(1)
i
= [M
(1)
i1
,M
(1)
i2
, · · · ,M(1)
is
], M
(2)
i
= [M
(2)
i1
,M
(2)
i2
, · · · ,M(2)
is
]
and M
(3)
i
= [M
(3)
i1
,M
(3)
i2
, · · · ,M(3)
is
] be a genes-derived SNP with s SNP markers, a ROI with r voxels
of the fMRI scan, and a gene-derived DNA methylation with d methylation profiles of the i-th
subject, respectively. Under this setting, Eq. (1), Eq. (2) and Eq. (3) become:
yi = X
T
i β + f (M
(1)
i
,M
(2)
i
,M
(3)
i
) + ǫi, (4)
f (M
(1)
i
,M
(2)
i
,M
(3)
i
) = hM(1)(M
(1)
i
) + hM(2)(M
(2)
i
) + hM(3)(M
(3)
i
) + hM(1)×M(2)(M
(1)
i
,M
(2)
i
)+
hM(1)×M(3)(M
(1)
i
,M
(3)
i
) + hM(2)×M(3)(M
(2)
i
,M
(3)
i
) + hM(1)×M(2)×M(3)(M
(1)
i
,M
(2)
i
,M
(3)
i
), (5)
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and
H = HM(1) ⊕ HM(2) ⊕HM(3) ⊕HM(1)×M(2) ⊕HM(1)×M(3) ⊕HM(2)×M(3) ⊕HM(1)×M(2)×M(3) , (6)
respectively. HereHM(1),HM(2) andHM(3) , andHM(1)×M(2) ,HM(1)×M(3) andHM(2)×M(3) , andHM(1)×M(2)×M(3)
are RKHSs functions onM1,M2 andM3, andM1×M2,M1×M3 andM2×M3 andM1,M2×M3,
respectively. The notation ⊕ is a direct sum of RKHS.
2.2 Model estimation
We can estimate the function f ∈ H by minimizing the penalized squared error loss function of Eq.
(4) as:
L(y,β, f ) = 1
2
n∑
i=1
[
yi − XTi β − f (M(1)i ,M
(2)
i
,M
(3)
i
)
]2
+
λ
2
J( f ) (7)
where J(·) = ‖ · ‖2H is a roughness penalty with tuning parameter λ. It is known that the complete
function space of Eq. (6), H , has the orthogonal decomposition. Hence the function J(·) can be
decomposed accordingly. Eq. (7) then becomes:
L(y,β, f ) = 1
2
n∑
i=1
[
yi − XTi β − hM(1)(M(1)i ) − hM(2)(M(2)i ) − hM(3)(M(3)i ) − hM(1)×M(2)(M(1)i ,M(2)i )
− hM(1)×M(3)(M(1)i ,M(3)i ) − hM(2)×M(3)(M(2)i ,M(3)i ) − hM(1)×M(2)×M(3)(M(1)i ,M(2)i ,M(3)i )
]2
+
λ(1)
2
‖hM(1)‖2 +
λ(2)
2
‖hM(2)‖2 +
λ(3)
2
‖hM(3)‖2 +
λ(1×2)
2
‖hM(1)×M(2)‖2 +
λ(1×3)
2
‖hM(1)×M(3)‖2
+
λ(2×3)
2
‖hM(2)×M(3)‖2 +
λ(1×2×3)
2
‖hM(1)×M(2)×M(3)‖2 (8)
=
[
y − Xβ − hM(1) − hM(2) − hM(3) − hM(1)×M(2) − hM(1)×M(3)
− hM(2)×M(3) − hM(1)×M(2)×M(3)
]2
+
λ(1)
2
‖hM(1)‖2 +
λ(2)
2
‖hM(2)‖2 +
λ(3)
2
‖hM(3)‖2
+
λ(1×2)
2
‖hM(1)×M(2)‖2 +
λ(1×3)
2
‖hM(1)×M(3)‖2 +
λ(2×3)
2
‖hM(2)×M(3)‖2 +
λ(1×2×3)
2
‖hM(1)×M(2)×M(3)‖2,
where y = [y1, y2, · · · , yn]T , X = [X1, X2, · · · , Xn]T , hM(1) = [hM(1)(M(1)1 ), hM(1)(M
(1)
2
), · · · , hM(1)(M(1)n )]T ,
hM(2) = [hM(2)(M
(2)
1
), hM(2)(M
(2)
2
), · · · , hM(2)(M(2)n )]T , hM(3) = [hM(3)(M(3)1 ), hM(3)(M
(3)
2
), · · · , hM(3)(M(3)n )]T ,
hM(1)×M(2) = [hM(1)×M(2)(M
(1)
1
,M
(2)
1
), hM(1)×M(2)(M
(1)
2
,M
(2)
2
), · · · , hM(1)×M(2)(M(1)n ,M(2)n )]T ,
hM(1)×M(3) = [hM(1)×M(3)(M
(1)
1
,M
(3)
1
), hM(1)×M(3)(M
(1)
2
,M
(3)
2
), · · · , hM(1)×M(3)(M(1)n ,M(3)n )]T ,
hM(2)×M(3) = [hM(2)×M(3)(M
(2)
1
,M
(3)
1
), hM(2)×M(3)(M
(2)
2
,M
(3)
2
), · · · , hM(2)×M(3)(M(2)n ,M(3)n )]T , hM(1)×M(2)×M(3) =
[hM(1)×M(2)×M(3)(M
(1)
n ,M
(2)
1
,M
(3)
1
), hM(1)×M(2)×M(3)(M
(1)
n ,M
(2)
2
,M
(3)
2
), · · · , hM(1)×M(2)×M(3)(M(1)n ,M(2)n ,M(3)n )]T ,
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λ(1), λ(2), λ(3), λ(1×2), λ(1×3), λ(2×3) and λ(1×2×3) are the positive tuning parameters that trade-off be-
tween the model fits and its complexity.
By the representer theorem (Kimeldorf & Wahhba, 1971; Scho¨lkopf & Smola, 2002) and the
fact that the reproduction kernel of a product of an RKHS is the product of the reproducing kernels
(Aronszajn, 1950), the expanded functions of f in Eq.(8) for arbitrary M˜(1) ∈ M(1), M˜(2) ∈ M(2)
and M˜(3) ∈ M(3) can be written as:
hM(1) =
n∑
i=1
α
(1)
i
k(1)(M˜(1),M
(1)
i
),
hM(2) =
n∑
i=1
α
(2)
i
k(2)(M˜(2),M
(2)
i
),
hM(3) =
n∑
i=1
α
(3)
i
k(3)(M˜(3),M
(3)
i
),
hM(1)×M(2) =
n∑
i=1
α
(1×2)
i
k(1)(M˜(1),M
(1)
i
)k(3)(M˜(1),M
(2)
i
),
hM(1)×M(3) =
n∑
i=1
α
(1×3)
i
k(1)(M˜(1),M
(1)
i
)k(3)(M˜(3),M
(3)
i
,
hM(2)×M(3) =
n∑
i=1
α
(2×3)
i
k(2)(M˜(2),M
(2)
i
)k(3)(M˜(3),M
(3)
i
),
hM(1)×M(2)×M(3) =
n∑
i=1
α
(1×2×3)
i
k(1)(M˜(1),M
(1)
i
)k(2)(M˜(2),M
(2)
i
)k(3)(M˜(3),M
(3)
i
).
For each data view, we can define the kernel matrices: K(1) = (k(1)(M1
i
,M1
j
))i j,K
(2) = (k(2)(M2
i
,M2
j
))i j,
K(3) = (k(3)(M3
i
,M3
j
))i j, K
(1×2) = K(1) ⊙ K(2), K(1×3) = K(1) ⊙ K(3), K(2×3) = K(2) ⊙ K(3) and
K(1×2×3) = K(1)⊙K(2)⊙K(3), where ⊙ is denoted as the element-wise product of two matrices. Now
we have
hM(1) = K
(1)α(1), hM(2) = K
(2)α(2), hM(3) = K
(3)α(3), hM(1)×M(2) = K
(1×2)α(1×2),
hM(1)×M(3) = K
(1×3)α(1×3), hM(2)×M(3) = K
(2×3)α(2×3), hM(1)×M(2)×M(3) = K
(1×2×3)α(1×2××3), (9)
where α(1) = [α
(1)
1
, α
(1)
2
, · · · , α(1)n ]T , α(2) = [α(2)1 , α
(2)
2
, · · · , α(2)n ]T , α(3) = [α(3)1 , α
(3)
2
, · · · , α(3)n ]T ,
α(1×2) = [α(1×2)
1
, α
(1×2)
2
, · · · , α(1×2)n ]T , α(1×3) = [α(1×3)1 , α
(1×3)
2
, · · · , α(1×3)n ]T , α(2×3) = [α(2×3)1 , α
(2×3)
2
, · · · , α(2×3)n ]T
and α(1×2×3) = [α(1×2×3)
1
, α
(1×2×3)
2
, · · · , α(1×2×3)n ]T .
Substituting hM(1), hM(2), hM(3) , hM(1)×M(2) , hM(1)×M(3) , hM(2)×M(3) and hM(1)×M(2)×M(3) into Eq. (8),
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and applying the reproducing kernel properties, we get
L(y,β,α) = 1
2
ǫT ǫ +
λ(1)
2
[α(1)]TK(1)α(1) +
λ(2)
2
[α(2)]TK(2)α(3) +
λ(3)
2
[α(3)]TK(3)α(3)
+
λ(1×2)
2
[α(1×2)]TK(1×2)α(1×2 +
λ(1×3)
2
[α(1×3)]TK(1×3)α(1×3) +
λ(2×3)
2
[α(2×3)]TK(2×3)α(2×3)
+
λ(1×2×3)
2
[α(1×2×3)]TK(1×2×3)α(1×2×3) (10)
where ǫ = y − Xβ − K(1)α(1) − K(2)α(2) − K(3)α(3) − K(1×2)α(1×2) − K(1×3)α(1×3) − K(2×3)α(2×3) −
K(1×2×3)α(1×2×3) and α = (α(1),α(2),α(3),α(1×2),α(1×3),α(2×3),α(1×2×3)).
The gradients of L with respect to the parametric coefficients β and nonparametric coefficients
α′s are
∂L
∂β
= XT ǫ,
∂L
∂α(1)
= [K(1)]T ǫ + λ(1)K(1)α(1),
∂L
∂α(2)
= [K(2)]T ǫ + λ(2)K(2)α(2),
∂L
∂α(3)
= [K(3)]T ǫ + λ(3)K(3)α(3),
∂L
∂α(1×2)
= [K(1×2)]T ǫ + λ(1×2)K(1×2)α(1×2),
∂L
∂α(1×3)
= [K(1×3)]T ǫ + λ(1×3)K(1×3)α(1×3),
∂L
∂α(2×3)
= [K(2×3)]T ǫ + λ(2×3)K(2×3)α(2×3),
∂L
∂α(1×2×3)
= [K(1×2×3)]T ǫ + λ(1×2×3)K(1×2×3)α(1×2×3) (11)
By setting the gradients to zero, this first-order condition is given by the linear system as follows:

XTX XTK(1) XTK(2) XTK(3) XTK(1×2) XTK(1×3) XTK(2×3) XTK(1×2×3)
[K(1)]TX A [K(1)]TK(2) [K(1)]TK(3) [K(1)]TK(1×2) [K(1)]TK(1×3) [K(1)]TK(2×3) [K(1)]TK(1×2×3)
[K(2)]TX [K(2)]TK(1) B [K(2)]TK(3) [K(2)]TK(1×2) [K(2)]TK(1×3) [K(2)]TK(2×3) [K(2)]TK(1×2×3)
[K(3)]TX [K(3)]TK(1) [K(3)]TK(2) C [K(3)]TK(1×2) [K(3)]TK(1×3) [K(3)]TK(2×3) [K(3)]TK(1×2×3)
[K(1×2)]TX [K(1×2)]TK(1) [K(1×2)]TK2 [K(1×2)]TK3 D [K(1×2)]TK(1×3) [K(1×2)]TK(2×3) [K(1×2)]TK(1×2×3)
[K(1×3)]TX [K(1×3)]TK(1) [K(1×3)]TK2 [K(1×3)]TK3 [K(1×3)]TK(1×2) E [K(1×3)]TK(2×3) [K(1×3)]TK(1×2×3)
[K(2×3)]TX [K(2×3)]TK(1) [K(2×3)]TK2 [K(2×3)]TK3 [K(2×3)]TK(1×2) [K(2×3)]TK(1×3) F [K(2×3)]TK(1×2×3)
[K(1×2×3)]TX [K(1×2×3)]TK(1) [K1×2×3]TK2 [K(1×2×3)]TK3 [K(1×2×3)]TK(1×2) [K1×2×3]TK(1×3) [K(1×2×3)]TK2×3 G


β
α(1)
α(2)
α(3)
α1×2
α1×3
α2×3
α1×2×3

=

XT y
K(1)y
K(2)y
K(3)y
K(1×2)y
K(1×3)y
K(2×3)y
K(1×2×3)y

, (12)
where A = [K(1)]TK(1) + λ(1)K(1), B = [K(2)]TK(2) + λ(2)K(2), C = [K(3)]TK(3) + λ(3)K(3), D =
[K(1×2)]TK(1×2)+λ(1×2)K(1×2), E = [K(1×3)]TK(1×3)+λ(1×3)K(1×3),F = [K(2×3)]TK(2×3)+λ(2×3)K(2×3)
G = [K(1×2×3)]TK(1×2×3) + λ(1×2×3)K(1×2×3). Following many derivations in the literature (e.g.,
(D. Liu et al., 2007; S. Li & Cui, 2012; Ge et al., 2015)), we can show that a first-order linear
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system is equivalent to the normal equation of the linear mixed effects model:
y = Xβ + hM(1) + hM(2) + hM(3) + hM(1)×M(2) + hM(1)×M(3) + hM(2)×M(3) + hM(1)×M(2)×M(3) + ǫ, (13)
where β is a coefficient vector of fixed effects, hM(1), hM(2) , hM(3) , hM(1)×M(2) , hM(1)×M(3) , hM(2)×M(3) and
hM(1)×M(2)×M(3) are independent random effects with distribution as hM(1) ∼ N(0, τ(1)K(1)), τ(1) = σ
2
λ(1)
,
hM(2) ∼ N(0, τ(2)K(2)), τ(2) = σ
2
λ(2)
, hM(3) ∼ N(0, τ(3)K(3)), τ(3) = σ
2
λ(3)
, hM(1×2) ∼ N(0, τ(1×2)K(1×2)), τ(1×2) =
σ2
λ(1×2) , hM(1×3) ∼ N(0, τ(1×3)K(1×3)), τ(1×3) = σ
2
λ(1×3) , hM(2×3) ∼ N(0, τ(2×3)K(2×3)), τ(2×3) = σ
2
λ(2×3) , hM(1×2×3) ∼
N(0, τ(1×2×3)K(1×2×3)), τ(1×2×3) = σ
2
λ(1×2×3) . ǫ is also an independent random variable with the distri-
bution ǫ ∼ N(0, σ2I), where I is an identity matrix. This relationship insures that all of the effects
extracted by minimizing the loss function in Eq. (7), are the same as the best linear unbiased pre-
dictors (BLUPs) of the linear mixed effects model in Eq. (13). It is possible to estimate the variance
components using the restricted maximum likelihood (ReML) approach (see in the appendix for
details). The solution of the linear system in Eq. (12) gives the coefficients of the fixed effect, β,
and coefficients for the random effect, α. By inserting α into Eq. (9), we can estimate the random
effects hˆM(1) , hˆM(2) , hˆM(3) , hˆM1×2 , hˆM(1×3) , hˆM(2×3) and hˆM(1×2×3) , respectively.
3 Statistical testing
Using positive definite kernels, we treat each gene-derived SNP, ROI, and gene-derived DNAmethy-
lation as a testing unit. In the following subsections, we study the test statistic of the overall effect
and higher order interaction effects.
3.1 Testing overall effect
We known that the overall testing effect H0 : hM(1)(·) = hM(2)(·) = hM(3)(·) = hM(1)×M(2)(·) =
hM(1)×M(3)(·) = hM(2)×M(3)(·) = hM(1)×M(2)×M(3)(·) = 0 is equivalent to test the variance components
in Eq.(13), H0 : τ
(1) = τ(2) = τ(3) = τ(1×2) = τ(1×3) = τ(2×3) = τ(1×2×3) = 0.
Unfortunately, under the null hypothesis, the asymptotic distribution of a likelihood ratio test
(LRT) statistic does not follow a chi-square distribution or a mixture chi-square distribution. Be-
cause the parameters in the variance components analysis are laid on the boundary of the parameter
space when the null hypothesis is true and kernel matrices are not block-diagonal, S. Li and Cui
(2012) have proposed a score test statistic based on the restricted likelihood. In this paper, we
have constructed a score test statistic for the multi-view data model, Eq. (13). Assuming that the
linear mixed model in Eq. (13) has multivariate normal distribution with mean Xβ and variance-
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covariance matrixΘ(θ) = σ2I+τ(1)K(1)+τ(2)K(2)+τ(3)K(3)+τ(1×2)K(1×2)+τ(1×3)K(1×3)+τ(2×3)K(2×3)+
τ(1×2×3)K(1×2×3), where θ = (σ2, τ(1), τ(2), τ(3), τ(1×2), τ(2×3), τ(1×2×3)) are the variance components.
The restricted log-likelihood function of Eq. (13) can be written as
ℓR(θ) = −1
2
ln(|Θ(θ)|) − 1
2
ln(|XTΘ−1(θ)X|) − 1
2
(y − Xβˆ)TΘ−1(θ)(y − Xβ) (14)
The estimate of the variance components are obtained by the partial derivative of Eq. (14) with
respect to each of the variance components (see appendix for more detail). By considering that the
true value of σ2 under the null hypothesis is σ2
0
, under the ReML the score test statistic is defined
as
S (σ20) =
1
2σ2
0
(y − Xβˆ)TK(y − Xβˆ) (15)
where K = K(1) + K(2) + K(3) + K(1×2) + K(1×3) + K(2×3) + K(1×2×3), βˆ is the maximum likelihood
estimator (MLE) of the regression coefficient under the null hypothesis y = Xβ + ǫ0, σ
2
0
is the
variance of ǫ0, and S (σ
2
0
) is the quadratic function for the variable y, which follows a mixture of
the chi-square distribution under the null hypothesis. By the Satterthwaite method (Satterthwaite,
1946), we can approximate the distribution of S (σ2
0
) to a scaled chi-square distribution, i.e., S (σ2
0
) ∼
γχ2ν , where the scale parameter γ and the degrees of freedom ν can be measured by the method of
moments (MOM). The mean and variance of the test statistic S (σ2
0
) are
E[S(σ20)] = E[γχ
2
ν] = γν, and Var[S(σ
2
0) = Var[[γχ
2
ν] = 2γ
2ν,
respectively. By solving the above two equations, we have γˆ =
Var[S(σ2
0
)]
2E[S(σ2
0
)]
and νˆ =
2E[S(σ2
0
)2]
Var[S(σ2
0
)]
. In
practices, σ2
0
is unknown but we can replace it by its ReML under the null model denoted by σˆ2
0
.
Lastly, the p−value of an experimental score statistic S (σˆ2
0
) is obtained using the scaled chi-square
distribution γˆχ2
νˆ
.
3.2 Testing higher order interaction effect
To test the higher order interaction effect, we show that testing the null hypothesis H0 : hM(1)×M(2)×M(3)(·) =
0 is equivalent to testing the variance component: H0 : τ
(1×2×3) = 0. Let Σ = σ2I + τ(1)K(1) +
τ(2)K(2) + τ(3)K(3) + τ1×2K(1×2) + τ1×3K(1×3) + τ2×3K(2×3), and τ(1), τ(2), τ(3), τ(1×2), τ(1×3), τ(2×3), and
σ2 are model parameters under the null model y = Xβ+hM(1)+hM(2)+hM(3)+hM(1)×M(2)+hM(1)×M(3)+ǫ.
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We formulate a test statistic:
S I(τI) =
1
2σ2
0
yTW01K
(1×2×3)W01y, (16)
where τI = (σ
2, τ(1), τ(2), τ(3), τ(1×2), τ(1×3), τ(2×3)), and W01 = Σ−1 − Σ−1X(XTΣ−1X)−1XTΣ−1 is
the projection matrix under the null hypothesis. Similarly to the overall effect test, we can use the
Satterthwaite method to approximate the distribution for the higher order intersection test statistic
S I(τI) by a scaled chi-square distribution with scaled γI and degree of freedom νI, i.e., S I(τI) ∼
γIχ
2
νI
. The scaled parameter and degree of freedom are estimated by the MOM, γˆI =
Var[SI(τI)]
2E[SI(τI)]
and
νˆI =
2E[SI(τI)]
Var[SI(τI)]
, respectively. In practice, the unknown model parameters τ(1), τ(2), τ(3), τ(1×2), τ(1×3), τ(2×3),
and σ2 are estimated by their respective ReML estimates τˆ(1), τˆ(2), τˆ(3), τˆ(1×2), τˆ(1×3), τˆ(2×3), and σˆ2
under the null hypothesis. Lastly, the p−value for the observed higher order interaction effect (score
statistic S I(τI)) is obtained using the scaled chi-square distribution γˆIχ
2
νˆI
.
3.3 Kernel choice
In kernel methods, choosing a suitable kernel is indispensable. Most kernel methods suffer from
poor selection of a suitable kernel. It is often the case that the kernel has parameters which may
strongly influence the results. Assuming k : X × X → R is a positive definite kernel. Then for any
X, X˜ ∈ X, a linear positive definite kernels on R is defined as
k(X, X˜) = 〈X, X˜〉 = XT X˜.
The linear kernel is used by the underlying Euclidean space to define the similarity measure. When-
ever the dimensionality of X is very high, this may allow for more complexity in the function class
than what we could measure and assess otherwise. The polynomial kernel is defined as
k(X, X˜) = (XT X˜ + c)d, (c ≥ 0, d ∈ N).
Using the polynomial kernel makes it possible to use higher order correlations between data for
different purposes. This kernel incorporates every polynomial interaction up to degree d (provided
that c > 0). For instance, if we want to take only the mean and variance into account, we only need
to consider d = 2 and c = 1. For more emphasis on mean we need to increase the constant offset a.
Polynomial kernels only map data into a finite dimensional space. Due to the finite bounded degree
the given kernel will not provide us with guarantees for a good dependency measure. In addition,
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both linear and polynomial kernels are unbounded.
Many radial basis function kernels, such as the Gaussian kernel, map X into a infinite dimen-
sional space. The Gaussian kernel is defined as:
k(X, X˜) = e
1
2σ2
−||X−X˜||2
, (σ > 0).
While the Gaussian kernel has a free parameter (bandwidth), it still follows a number of theoretical
properties such as boundedness, consistence, universality, robustness etc. It is the most applicable
kernel of the kernel methods (B. K. Sriperumbudur & Scho¨lkopf, 2009). For the Gaussian kernel,
we can use the median of the pairwise distance as a bandwidth (Gretton et al., 2008; Song, Smola,
Gretton, Bedo, & Borgwardt, 2012).
For GWASs, a kernel captures the pairwise similarity across a number of SNPs in each gene.
Kernel projects the genotype data from original space (high dimension and nonlinear) to a feature
space (linear space). One of the more popular kernels used for genomics similarity is the identity-
by-state (IBS) kernel (nonparametric function of the genotypes) (L. C. Kwee, 2008):
k(Mi,M j) = 1 − 1
2s
s∑
b=1
|Mib − M jb|.
where s is the number of SNP markers of the corresponding gene. The IBS kernel does not need
any assumption on these types of genetic interactions. Thus, in principle, it can capture any effect
between genetic features and their influences on the phenotype. In this paper, we used the Gaussian
kernel for the quantitative data view (imaging and epigenetics) and the IBS kernel for the qualitative
data view (genetics).
4 Relevant methods
Li and Cui (2012) have proposed a linear PCA (LPCA) based regression method for the interaction
effect between two genes. This makes it possible to extend the notion to three datasets. LetM(1) =
[M1
1
,M1
2
, · · · ,M1s ], M(2) = [M21 ,M22, · · · ,M2r ], and M(3) = [M31,M32, · · · ,M3d] be the data matrix
for the genetics, imaging and epigenetics, respectively. Using the PCA we can compute the first
ℓ principle components: U1
1
,U1
2
, · · ·U1sℓ , U21 ,U22 , · · ·U2rℓ , and U31 ,U32 , · · ·U3dℓ with sℓ ≤ s, rℓ ≤ r,
and dℓ ≤ d, for the corresponding data matrix, respectively. We then compared the numerical,
simulation and real data analysis with the following methods: test based on only first and first
few principal components multiple regression, which we are called partial principal component
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regression (pPCAR) and full principal component regression (fPCAR)), respectively.
4.1 Principal component multiple regression
By considering only the first principal component, the 3rd order interaction model ( i.e., pPCA) can
be stated as:
y = Xβ +
s∑
a=1
αaM
(1)
a +
r∑
b=1
αbM
(2)
b
+
d∑
c=1
αcM
(3)
c + ηU
(1)
1
U
(2)
1
U
(3)
1
. (17)
This model is called partial PCA regression (pPCAR). Using the multiple regression in Eq. (17),
the interaction of M(1) ×M(2) ×M(3) is assessed by testing H0 : η = 0. To consider all possible
interactions of the selected principal components, we can also replace the main effects by the first
ℓ principal components. The number of principal components ℓ is selected based on the proportion
of variation explained by the principal components, which can explain the major variations (say,
≥ 85%). The models in Eq. (17) then becomes
y = Xβ +
sℓ∑
a=1
αaU
(1)
a +
rℓ∑
b=1
αbU
(2)
b
+
dℓ∑
c=1
αcU
(3)
c +
sℓ∑
a=1
rℓ∑
b=1
dℓ∑
c=1
η123U
(1)
a U
(2)
b
U
(3)
c (18)
Using the multiple regression in Eq. (18), the interaction ofM(1)×M(2)×M(3) is assessed by testing
H0 : η123 = 0.
4.2 Principal component sequence kernel association test
Over the past several years, the sequence kernel association test (SKAT) approach has been widely
used in GWASs due to its flexibility and computational efficiency. The SKAT is based on a SNP-set
(e.g., a gene or a region) level test for the association between a set of variants and dichotomous or
quantitative phenotypes. This method aggregates individual test statistics of SNPs and efficiently
computes SNP-set level p-values, while adjusting for covariates, such as principal components to
account for population stratification (M. C. Wu et al., 2011; I. Ionita-Laza, 2013). We applied SKAT
to gene-derived SNPs, ROIs, and gene-derived DNA methylations data. To do this, we use SKAT
in Eq. (18) and the interaction ofM(1) ×M(2) ×M(3) is assessed by testing H0 : η123 = 0.
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5 Experiments
We conducted experiments on both the simulation studies (numerical data and real MCIC data) and
imaging genetics with the SZ study. We considered the IBS kernel for the genetic data and the
Gaussian kernel for all other data. For the Gaussian kernel, we used the median of the pairwise
distance as the bandwidth. The proposed method is based on the ReML algorithm (Fisher’s scor-
ing algorithm). The ReML algorithm converged in less than 50 iterations (the difference between
successive log ReML values was smaller than 10−04), and in most of the cases it converged very
quickly with 10 iterations, taking only a few seconds with an R-program. Solving the ReML may
be trapped by local minima. To avoid this problem, we use a set of initial points (0, 0.00001, 0.0001,
0.001, 0.01, 0.1, 1) for the optimization algorithm and chose the best one (maximized ReML).
5.1 Simulation studies
The goal of these simulation studies is to evaluate the performance of the proposed method and the
accuracy of the score tests. To synthesize quantitative phenotypes, we applied the following model:
yi = X
T
i β + α1 [hS (S i) + hT (Ti) + hC(Ci)] + α2 [hS×T (S i, Ti) + hS×C(S i,Ci) + hT×C(Ti,Ci)]
+ α3 [hS×T×C(S i, TiCi)] + σǫi (19)
where Xi is a vector of covariates including an intercept (e.g., age, height, etc.,) of ith subject
(i = 1, 2, · · · , n) and β’s are the coefficient. S i, Ti, and Ci are the three data sets and ǫi is a random
error that follows the Gaussian distribution with mean zero and unit variance, i.e., ǫi ∼ N(0, 1), and
σ is the standard deviation of the error and was fixed to 10−02, of the i−th subject. For each function,
we designed the following form
hS (S i) =
∑10
a=1 S [i, a]cos(S[i, a]), hT(Ti) =
∑2
b=1 2T[i, b]sin(T[i, b]), hC(Ci) =
∑10
c=1
i√
2 exp(C[i,c])
,
hS×T(Si,Ti) = hS(Si)2hT(Ti), hS×C(Si,Ci) = hS(Si)3hC(Ci), hT×C(Si,Ti) = 2hT(Ti)3hC(Ci),
hS×T×C(Si,Ti,Ci) = hS(Si)2hT(Ti)3hC(Ci).
In simulation-I and simulation-II, we generated data under different values of (α1, α2, α3) to
evaluate the performance of the test. In other words, for α1 = α2 = α3 = 0 both main effects and
all interaction effects vanish and we examined the false positive rate of the score test of the over all
effect. For α1 ≥ 0, α2 = 0 ( α2 ≥ 0) and α3 = 0, there are main effects (2nd order interaction effects)
but no higher order interaction effects, hence we can evaluate the power of the score test. We also
set (α1, α2, α3) to many different values to test the power of both score tests. In each setting 500
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simulations were performed to confirm the variation of the results.
5.1.1 Simulation-I (numerical data)
In this simulation, we generated two covariates (height and weight) and three views (genetics, topo-
logical, and categorical data). We generated the height and weight by the regular sequencing of the
interval (50, 80) and (60, 225) with increment of 2.05 and 4.7 for the n = 500 subject, respectively.
Then, we added the noise 3N(0, 1) to each of the variables. The element of coefficient vector β
is fixed to 0.5. For the genetics data, we simulated a gene with 10 SNPs using the latent model
for 500 subjects as in (Parkhomenko, Tritchler, & Beyene, 2009; Alam, Komori, et al., 2016). We
generated data along three circles of different radii with small noise for topological features (Alam
& Fukumizu, 2014):
Ti = ri
cos(Ri)sin(Ri)
 + ǫi,
where ri = 1, 0.5 and 0.25, for i = 1, . . . , n1, i = n1 + 1, . . . , n2, and i = n2 + 1, . . . , n3 (n = n1 + n2 +
n3 = 500), respectively, Ri ∼ U[−1, 1] and ǫi ∼ N(0, I2) independently. For the categorical data,
we considered 10 categories with probability 1/10 and converted these features into the dummy
features with levels zero and one.
In addition, to draw the receiver operating characteristic (ROC) the data was generated by fixing
α1 = 1, α2 = 1 and α3 was allocated with probability 0.5 for each run, whether a random number
was uniformly distributed on [0, 1] or at 0 . We also only fixed α1 = 1 and for each run α3 (α2= α3)
was allocated with probability 0.5, whether a random number is uniformly distributed on [0, 1] or
at 0. We considered three sample sizes n ∈ {100, 500, 1000} and compared the ROC curves of the
proposed method with the three state-of-the-art methods in identifying the interaction effects.
5.2 Simulation-II (Mind Clinical Imaging Consortium’s schizophrenia data)
To validate Eq. (19) under different values of (α1, α2, α3), we consider real data. This simulation
was based on the SZ data which was collected by the MCIC (J. Chen et al., 2012; J. Liu et al., 2014;
Chekouo et al., 2016). These are 208 subjects including 92 schizophrenic patients (age: 34 ± 11,
22 females) and 116 (age: 32 ± 11, 44 females) healthy controls. All participants’ symptoms were
evaluated by the scale for the assessment of positive symptoms and negative symptoms (Andreasen,
1984). By filtering missing data, the number of subjects was reduced to 182 subjects (79 SZ patients
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and 103 healthy controls). We considered the age, height, and weight as the covariates and gene-
derived SNP, ROIs with voxels, and gene-derived DNA methylation information as the three views.
Genetics: For each subject (SZ patients and healthy controls) a blood sample was taken and
DNA was extracted. Gene typing was performed for all subjects at the Mind Research Network
using the Illumina Infinium HumanOmni1- Quad assay covering 1140419 SNP loci. To form the
final genotype calls and to perform a series of standard quality control procedures the bead stu-
dio and PLINK software packages were applied, respectively. The final dataset spans 722177
loci with 22442 genes of 182 subjects. Genotypes “aa” (non-minor allele), “Aa” (one minor al-
lele) and “AA” (two minor alleles) were coded as 0, 1 and 2 for each SNP, respectively (Alam,
Komori, et al., 2016). A list of the top 75 genes for the SZ are listed in the SZ genes database
(https : //bioinfo.uth.edu/SZGR/).
Imaging: Participants’ fMRI data were collected during a block design motor response for
auditory stimulation. State-of-the-art approaches using participant feedback and expert observation
were used. The aim was to continuously monitor the patients while acquiring images with the
parameters (TR=2000 ms, TE= 30ms, field of view=22cam, slice thickness=4mm, 1 mm skip, 27
slices, acquisition matrix 64 × 64, flip angle=90◦) on a Siemens 3T Trio Scanner and 1.5 T Sonata.
The data comes from four different sites (& scanners) with echo-planar imaging (EPI). Data were
pre-processed with SPM software and were realigned spatially, normalized and resliced to 3× 3× 3
mm. They were smoothed with a 10 × 10 × 10 mm3 Gaussian kernel and then analyzed by multiple
regression that considered the stimulus and their temporal derivatives plus an intercept term as a
regressors. Finally the stimulus-on versus stimulus-off contrast images were extracted. Next, 41236
voxels were extracted from 116 ROIs based on the AAL brain atlas for analysis (Alam, Calhoun,
& Wang, 2016). For imaging features (ROIs), we considered 116 ROIs. The name for the ROIs is
given by the automated anatomical labeling (AAL) template (Yan & Zang, 2010).
Epigenetics: DNA methylation is one of the main epigenetic mechanisms to regulate gene
expression, and may be involved in the development of SZ. For this paper, we investigated 27481
DNAmethylation markers in blood from SZ patients and healthy controls. DNA from blood samples
were measured by the Illumina Infinium Methylation27 Assay. The methylation value is calculated
by taking the ratio of the methylated probe intensity and the total probe intensity.
In this paper, the top 72 genes (from https : //bioinfo.uth.edu/SZGR/ and genes have more
than one SNP), 116 ROIs, and form DNA methylation 129 genes (genes have more than 5 methyla-
tions) are considered as gene-derived SNPs, ROIs with voxel, and gene-derived DNA methylations
features, respectively.
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5.3 Simulation results
Table 1 presents the simulation results (simulation-I and simulation-II) for the overall and higher
order interaction tests. The nominal p−value threshold was fixed to 0.05. By observing this table,
we can see that when α1 = α2 = α3 = 0, the size of the overall score test is close to the nominal
p−value threshold. When α1 ≥ 0, α2 = 0 (or (α2 ≥ 0)) and α3 = 0, the false positive rate of
the test for higher order interaction effects is also controlled. For the power analysis (α3 ≥ 0) we
found that the power of the interaction test for the proposed method quickly exceeds 0.85 and 0.90
for simulation-I and simulation-II, respectively. While the SKAT method has higher power when
compared to other relevant methods (pPCAR and fPCA) it has lower power when compared to the
proposed method both in simulation-I and in simulation-II. We observed that dimension reduction
methods (pPCAR and fPCA) can significantly inflate the false positive rates and dramatically loses
power when compared to the proposed one and SKAT methods.
Figure 2 shows the receiver operating characteristics (ROC) of the proposed method and three
alternative methods to detect interactions using the simulation-III with three sample sizes, n ∈
{100, 500, 1000} for (a) third parameter value is random only, (b) second and third parameter values
are random. The sensitivity are plotted against (1- specificity) with the p-values threshold in the
range 0 − 1 with a step size 0.0001. The power gain of the proposed method relative to the alterna-
tive methods is evident in all situations. When the sample size was increased, and the second order
interaction was equal to one, a higher power was observed. We also observed extremely high power
for the similar second and higher order interactions.
5.4 Application to imaging genetics and epigenetics with schizophrenia
Here it is demonstrated the power of our proposed method and SKAT utilization for imaging genetic
and epigenetic SZ data collected by MCIC. The key to integration, here, is to characterize the under-
lying interactions between the genetic features (gene-derived SNPs), human brain features (ROIs)
and epigenetic features (gene-derived DNA methylation) with covariates (age, height, weight) on
hippocampal volume derived from structural MRI scans of the SZ. To do this, we extracted signif-
icant (gene-derived SNPs)-ROI-(gene-derived DNA methylations) interactions using the proposed
method and compared them to the SKAT methods.
By considering 72 genes-derived SNP, 116 ROIs and 129 gene-derived DNA methylation, we
have 1077408 (72×116×129) triplets. By the overall tests, we obtained 15436 significant triplets at
a 5% level (p ≤ 0.05). Figure 3 visualizes the index plot of −log10(p) for 15436 triplets (the triplets
in X-axis and −log10(p) in Y-axis). The vertical solid, doted and double doted lines indicate the
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Table 1: Power of the overall and higher order interaction score tests, and the alternative methods
for interaction detection based on dimension reduction regression (pPCAR, fPCAR) and sequence
kernel association test (SKAT). The nominal p−values threshold was fixed to 0.05.
Parameters Simulation - I Simulation-II
KMDHOI State-of-the-art methods KMDHOI State-of-the-art methods
pPCAR fPCAR SKAT pPCAR fPCAR SKAT
(α1, α2, α3) Overall HOI HOI HOI HOI Overall HOI HOI HOI HOI
(0, 0, 0) 0.047 0.003 0.044 0.036 0.052 0.055 0.009 0.046 0.056 0.045
(0.5, 0, 0) 1.00 0.000 0.137 0.041 0.127 0.999 0.339 0.172 0.077 0.188
(1, 0, 0) 1.00 0.000 0.060 0.015 0.143 0.999 0.457 0.199 0.077 0.176
(0, 0.5, 0) 1.00 0.336 0.137 0.053 0.160 1.000 0.882 0.189 0.095 0.261
(0, 0.5, 0.5) 1.00 0.745 0.161 0.093 0.410 1.000 0.899 0.199 0.107 0.288
(0, 0.5, 1) 1.00 0.843 0.157 0.082 0.478 1.000 0.904 0.173 0.092 0.305
(0, 0,0.1) 1.00 0.813 0.173 0.080 0.787 1.000 0.924 0.231 0.132 0.362
(0, 0,1) 1.00 0.882 0.213 0.110 0.748 1.000 0.918 0.283 0.115 0.351
(0.5, 0.5, 0.5) 1.00 0.765 0.174 0.107 0.403 1.000 0.872 0.151 0.117 0.381
(1,1,1) 1.00 0.785 0.207 0.111 0.526 1.000 0.896 0.190 0.110 0.405
Figure 2: Receiver operating characteristics (ROC) of the kernel methods and relevant methods
for higher order interaction detection with three sample sizes, n ∈ {100, 500, 1000} for (a) third
parameter value is random, (b) second and third parameter values are random. The sensitivity are
plotted against (1- specificity) with the p-values threshold in the range zero to one (0 − 1) with a
step size 0.0001.
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p-values at 0.05, 0.01, 0.001, respectively. Based on these lines, we observed that 272, 72, and 13
triplets are identified to have significantly higher order interactions at 0.05, 0.01 and 0.001 levels,
respectively.
Table 2 presents the ReML estimates of σ2, τ(1), τ(2), τ(3), τ(1×2), τ(1×3), τ(2×3), τ(1×2×3) and the
p-values for the proposed and SKAT methods on each of the 13 triplets, which are identified to have
interaction significance at a level of 0.001. At this p-value, we have 6 gene-derives SNPs (IL1B,
MAGI2, NRG1, PDLIM5, SLC18A1, TDRD3), 10 ROIs (CRBL8.L, CRBLCrus1.L, ORB-
SUP.R, LING.L, CAU.R, IPL.L, IPL.R, PoCG.L, ITG.R, VER54), and 6 gene-derived DNA
methylations (CRABP1, FBXO28, DUSP1, FHIT, PLAGL1, TFPI2) that have significant inter-
action effects on the hippocampal volume of SZ patients.
Figure 4 shows the network within each genetics, imaging and epigentics interactions as well as
the interactions they have between all others views. Each node represents the gene-derived SNPs,
ROIs and gene-derived DNA methylations, respectively. The interacting genes-derived SNPs, ROIs
and gene-derived DNA methylations are connected with lines. The thickness of the connection line
indicates the strength of the interaction among genes-derived SNPs, ROIs and gene-derived DNA
methylations. These selected gene-derived SNPs and gene-derived DNA methylations show the
interactions between several other genes. The selected ROIs also show the interaction within each
selected ROI (shown in Figure 4) as well as the other ROIs (not shown in the figure). Following
many studies in the literature, we have shown that each selected gene-derived SNPs our method has
identified also has robust research discussing its role in the expression of SZ disease (Siawa, Liuc,
Linc, Beend, & Hsiehc, 2016; Shibuya et al., 2013; Koide, Banno, Aleksic, & et al., 2013; Harrison
& Law, 206; Moselhy, Eapenb, Akawi, Younis, & et. al., 2015; Bly, 2005).
Recent research has also shown that the 10 ROIs selected by the proposed method have a critical
role in brain related diseases (Suk, Wee, Lee, & Shen, 2016; Z. Chen, Liu, Gross, & Beaulieu, 2013;
K. Wu et al., 2013). We additionally investigated the 10 ROIs to confirm their role in SZ. To do this,
each multidimensional variable ROI was converted to a univariate variable by taking the weighted
mean. We then evaluated the differences between the SZ candidates and healthy controls using
network measures and visualizations. Table 3 presents the transitivity, degree and global efficiency
of each ROI for the SZ candidate and network and healthy control. From this table, we observed
that the transitivity (measuring the probability that the adjacent vertices of a vertex are connected)
of the SZ candidate group is larger than in the healthy control group (most of the ROIs and on
average); this suggests that SZ tends to have more transitive triples. The degree (the number of
edges incident to the vertex) of the SZ candidate group is larger than in the healthy control group
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for all of the ROIs; this indicates that these ROIs could have an impact on the SZ candidate. The
global efficiency, the mean of all nodal efficiencies, of the SZ candidate group is different from the
healthy control group. This may suggest that functional activity of the SZ candidate is not similar to
the functional activity of the healthy control group in these regions. Figure 5 shows the visualization
of correlation matrices, axial view with all networks and networks with correlation > 0.05 for the
SZ candidate and healthy control group. From Figure 5, it can be observed that the ROIs in the SZ
candidate groups are more correlated and connected than the healthy control group. Therefore, with
strong agreement, it has been shown that the selected ROIs have potential impact on the expression
of SZ disease.
Table 4 lists the selected significant gene-derived SNP, ROIs and gene-derived DNA methyla-
tion using the proposed method (KMDHOI) and SKAT at a p ≤ 0.01. We found that 31 genes-
derived SNP, 35 ROIs and 20 genes-derived DNA methylation from 72 triplets were identified to
have significance on the hippocampal volume of the SZ patients and the healthy controls. We also
observed that 6 gene-derived SNPs, 10 ROIs and 6 gene-derived DNAmethylations were significant
at a p ≤ 0.001. The underlined elements indicated in Table 4 have significant interaction triplets.
Table 5 & 6 (in the appendix) lists 72 triplets, which were significant at a p ≤ 0.001.
For the proposed KMDHOI approach, we considered triplets (gene-derived SNP, ROI, gene-
derived DNA methylation) with a p ≤ 4−8 to be statistically significant after the Bonferroni cor-
rection for 1077408 tests. Although the interaction (gene-derived SNP, ROI, gene-derived DNA
methylation) results do not appear to be significant after adjusting for multiple comparisons, some
of them appear promising consistent results. According to the p−values, we can determine the
gene-derived SNPs, ROIs, and gene-derived DNA methylations that have a highly significant hip-
pocampal volume on SZ patients and healthy controls. We observed gene-derived SNP (MAGI2,
NRG1, SLC18A1, TDRD3), ROIs (CRBL8.L, CRBLCrus1.L, ORBSUP.R, LING.L, IPL.L,
IPL.R) and gene-derived DNA methylations (CRABP1, FBXO28, FHIT, PLAGL1) at a p ≤
0.0001, gene-derived SNP (MAGI2, NRG1, TDRD3), ROIs (CRBL8.L, CRBLCrus1.L, IPL.L,
IPL.R) and gene-derived DNA methylation (FBXO28, PLAGL1) at a p ≤ 0.00001, and genes-
derived SNP (MAGI2), ROIs (CRBLCrus1.L), and gene-derived DNA methylation (FBXO28) at
a p ≤ 0.000001, which are identified to have high interaction effects on hippocampal volume of SZ
patients and healthy control.
To confirm this discovery, we used the DAVID, and gene ontology (GO) enrichment analysis
to find the most relevant GO terms associated with the selected 31 genes. The selected genes are
associated with a set of annotation terms. We compared 5 annotation categories, including litera-
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ture, disease, gene ontology, pathways and protein interaction using DAVID (Huang, Sherman, &
Lempicki, 2009). Table 7 (in the appendix) presents five annotation categories of the 31 selected
genes. From this table, we observed that the selected genes have had remarkable literature review
done in past studies. According to the disease annotation, the selected genes are highly associated
with complex diseases including SZ, cognitive function, bipolar disorder, and others. By GO an-
notation, the selected genes have significant relationship to single-organism processes, response to
stimuli, developmental processes and etc. From the table, we observed that the selected genes have
a significant pathway to facilitate biological interpretation in a network context. Moreover, protein
interaction annotations show that the selected genes have been discussed in many biomedical papers
(Sanders, Duan, Levinson, & et. al., 2008; Gerhard, Wagner, Feingold, & et al., 2004; Strausberg,
Feingold, Grouse, & et al., 2002).
Genes do not function alone. Rather, they interact with each other. When genes share a sim-
ilar set of GO annotation terms, they are most likely to be involved in similar biological mecha-
nisms. To confirm this, we extracted the (gene-derived SNPs)-(gene-derived DNA methylations)
network using STRING (Szklarczyk et al., 2007). STRING imports protein association knowledge
from databases of physical interaction and databases of curated biological pathway knowledge. In
STRING, the simple interaction unit is the functional association (functional relationship between
two proteins/ genes) that is most likely contributing to a common biological purpose. In this view,
the color saturation of the edges represents the confidence score of a functional association. Further
network analysis shows that the number of nodes, expected number of edges, number of edges,
average node degree, clustering coefficient, PPI enrichment p-values are 51, 93, 300, 11.8, 0.603,
and p ≤ 0× 10−16, respectively (Szklarczyk et al., 2007). This network has significantly more inter-
actions than expected. This means that these genes have more interactions among themselves than
what would be expected for a random set of genes of similar size drawn from the genome. Such an
enrichment indicates that the proteins/genes are at least biologically connected as a group.
Lastly, we conducted standard logistic regression analysis with covariates of age, gender, and
BMI on the outcome of SZ disease (SZ vs healthy control). We found that BMI is a significant
covariate for the SZ vs healthy control at a p ≤ 0.0353. Thus, BMI is one of the risk factors of
SZ disease. For a BMI ≥ 25, we considered the subject to be a high risk. Based on this risk, we
divided the estimated higher order interaction effect hˆM(1)×M(2)×M(3) values into four regimes: SZ
with high BMI risk, SZ with low BMI risk, healthy control with high BMI risk, and healthy control
with low BMI risk. Figure 6 shows the boxplots of the estimated interaction effect within each
of the four regimes for the most significant triplet (MAGI2, CRBLCrus1.L, and FBXO28). The
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Figure 3: The plot of −log10(p) with 15436 triplets.
Table 2: The selected significant genes-derived SNP, ROIs and gene-derived DNA methylation
using the proposed method (KMDHOI) and SKAT. The p−values threshold was fixed to 0.001.
KMDHOI SKAT
Genetics Imaging Epigenetics σ2 τ(1) τ(2) τ(3) τ1×2 τ1×3 τ2×3 τ1×2×3 OVA HOI HOI
IL1B CAU.R FBXO28 0.6755 0.0038 0.0229 0.1225 1.1013 0.0000 0.1307 1.3606 0.0383 2E − 04 0.4943
IL1B PoCG.R FBXO28 0.5837 0.0189 0.1827 0.1247 1.8403 0.0000 0.3469 1.0603 0.0202 7E − 04 0.2871
MAGI2 CRBLCrus1.L FBXO28 0.1833 0.3246 0.0000 0.2693 1.1963 2.2426 1.3683 0.0100 0.0288 0E − 06 0.01891
MAGI2 LING.L CRABP1 0.1813 0.4366 0.0000 0.0885 1.5370 2.6299 1.0271 0.0100 0.0470 0E − 05 0.4030
MAGI2 IPL.R FBXO28 0.1833 0.3778 0.0000 0.3044 0.9808 2.3888 1.2203 0.0100 0.0457 0E − 05 0.5592
NRG1 IPL.L PLAGL1 0.3682 0.0024 0.2162 0.1270 1.1227 2.7930 0.0000 0.2056 0.0284 0E − 05 0.6664
PDLIM5 IPL.L DUSP1 0.3648 0.0000 0.0804 0.2182 1.5177 1.9409 1.0276 0.0100 0.0183 5E − 04 0.0173
PDLIM5 PoCG.R DUSP1 0.3598 0.0000 0.2256 0.0139 0.9189 1.7853 1.2796 0.0100 0.0498 Ee − 04 0.2761
SLC18A1 ORBsup.R FHIT 0.4096 0.0065 0.5356 0.2276 1.3456 0.0000 1.0003 0.1323 0.0495 1E − 04 0.0522
SLC18A1 ORBsup.R PLAGL1 0.2869 0.0000 0.3909 0.1933 1.0186 1.3148 1.3676 0.0100 0.0373 3E − 04 0.0149
SLC18A1 Vermis45 TFPI2 0.5571 0.0447 0.0815 0.0020 0.0000 1.0458 0.5579 0.0100 0.0354 7E − 04 0.4234
TDRD3 CRBL8.L FBXO28 0.5856 0.2284 0.0022 0.0702 1.1722 0.7667 0.0000 0.0100 0.0052 0E − 05 0.0807
TDRD3 ITG.R CRABP1 0.5291 0.2318 0.0000 0.0223 0.7052 0.6038 0.6240 0.0100 0.0033 4E − 04 0.0359
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Figure 4: The network graph of features interaction of each individual view and features interac-
tions of among others view (p ≤ 0.001). Each node represents genes-derived SNP ( G1: IL1B, G2:
MAGI2,G3: NRG1,G4: PDLIM5,G5: SLC18A1,G6: TDRD), ROIs (R1: CRBL8.L,R2: CR-
BLCrus1.L, R3: ORBSUP.R, R4: LING.L, R5: CAU.R, R6: IPL.L, R7: IPL.R, R8: PoCG.L,
R9: ITG.R, R10: VER54) and gene-derived DNA methylation (E1: CRABP1, E2: FBXO28, E3:
DUSP1, E4:FHIT, E5: PLAGL1, E6: TFPI2).
Table 3: The network measurements (transitivity, degree, and global efficiency) of the selected 10
ROIs for schizophrenia candidate and healthy control groups.
Transitivity Degree Global efficiency
ROIs Schizophrenia Healthy Schizophrenia Healthy Schizophrenia Healthy
R1 = CRBL8.L 0.571 1.000 7 2 0.800 0.317
R2 = CRBLCrus1.L 0.600 0.333 6 3 0.750 0.400
R3 = ORBSUP.R 0.667 0.000 3 1 0.5833 0.100
R4 = LING.L 0.667 0.333 7 3 0.800 0.400
R5 = CAU.R 0.700 0.000 5 1 0.683 0.100
R6 = IPL.L 1.000 1.000 2 2 0.500 0.317
R7 = IPL.R 0.667 1.000 4 2 0.650 0.317
R8 = PoCG.L 0.667 1.000 7 2 0.800 0.3167
R9 = ITG.R 0.900 0.000 5 1 0.683 0.100
R10 = VER45 0.800 0.000 6 1 0.750 0.100
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Figure 5: The visualization of selected 10 ROIs for schizophrenia candidate and healthy control
groups: (a) correlation matrices, (b) axial view with all networks, (c) networks with correlation
> 0.5.
Table 4: The selected significant gene-derived SNPs, ROIs and gene-derived DNA methylations
using the proposed method (KMDHOI) and SKAT at p ≤ 0.01. The bold indicates significant at
p ≤ 0.001. Note: the name of ROI is given by the AAL template.
Genetics IL1B MAGI2 NRG1 PDLIM5 SLC18A1 TDRD3 BDNF CHGA CHGB CLINT1
COMTD1 DAOA DISC1 DRD2 DTNBP1 ERBB4 GABBR1 GABRB2 GRIN2B GRM3
HTR2A IL10RA MAGI1 MICB NOS1AP NOTCH4 NR4A2 NUMBL PLXNA2 PPP3CC
SNAP29
Imaging CRBL8.L CRBLCrus1.L ORBSUP.R LING.L CAU.R IPL.L IPL.R PoCG.L ITG.R VER45
AMYG.L CRBL10.R CRBL10.L CRBL3.R CRBL3.R CRBL45.L CRBL6.L CRBL8.R CRBLCrus2.R CRBLCrus2.L
DCG.R DCG.L PCG.R ORBsup.L ORBmid.R LING.R ROL.R SMA.R TPOsup.R TPOsup.L
STG.L ITG.L Vermis10 Vermis3 MTG.R
Epigenetic CRABP1 FBXO28 DUSP1 FHIT PLAGL1 TFPI2 CCND2 CDKN1A EDNRB ESR1
EYA4 FEN1 GPSN2 HOXA9 HOXB4 PTGS2 RB1 SRF WDR37 ZNF512
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small variation indicates a higher risk of the interaction effect (hippocampal volume). This figure
shows that the SZ and BMI risks largely dominate the interaction effect (i.e., higher SZ and BMI
risk associated with higher risk of interaction) and vice versa.
Figure 6: Boxplost of significant interaction effects in different regimes (SZ and high BMI risk, SZ
and low BMI risk, healthy control and high BMI risk, healthy control and low BMI risk) for the
most significant triplet (MAGI2, CRBLCrus1.L, FBXO28).
6 Discussion and future research
In this paper, we have proposed a semiparametric kernel method for higher order interactions be-
tween multiple data sets. Compared to the traditional PCA multiple regression and SKAT methods,
the proposed method shows a more flexible and biological plausible way to model higher order epis-
tasis among the genetic, imaging, and epigenetic data. While kernel based methods on multi-view
data naturally produce more powerful and reproducible results, and are biologically more meaning-
ful, the interpretation of model parameters is often challenging. Incorporating the gene and pathway
analysis of biological information would facilitate additional improvements of model interpretation.
The performance of the proposed method was evaluated on both simulated and real MCIC data.
The extensive simulation studies show evidence of the power gain of the proposed method relative
to the alternative methods and suggest that the proposed methods perform remarkably better than
the dimension reduction multiple regression and SKAT methods.
The utility of the proposed method is further demonstrated with the application to imaging ge-
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netics study of SZ. According to the p−values, the proposed method is able to rank the triplets
(gene-derived SNPs)-ROI-(gene-derived DNA methylations) and subset of triplets can be selected
which are highly related to SZ disease. At a p ≤ 0.01 the proposed method extract the unique
31 genes-derived SNP, 35 ROIs and 20 gene-derived DNA methylation from 72 triplets, which are
identified to have significant impact on hippocampal volume of SZ patients. By conducting gene on-
tology, pathway analysis, and several network measures including visualizations, we find evidence
that the selected (gene-derived SNPs)- ROI-(gene-derived DNA methylations) have a significant
influence on the manifestation of SZ disease. The identified triplets suggest that these statistical
and biologically significant triplets may an important role in SZ related neurodegenerations. Our
findings have indicated that genetic elements interplay with brain regions and epigenetic factors.
While we illustrated the proposed model using a quantitative hippocampal volume derived from
structural MRI image phenotype, the utility of this model is that it can be applied to any pheno-
types to detect higher order interactions in genetics, imaging, and epigenetic features, to include
environmental covariates. The proposed model can also be extended to qualitative phenotypes for
potentially widely applicable case-control studies (e.g., generalized kernel logistic regression).
It must be repeated that choosing a suitable kernel is indispensable. Kernel parameters may
strongly influence the result desired for its application. Although the linear kernel does not have
any free parameters, the linear kernel has certain limitations. Using the polynomial kernel makes
it possible to detect higher order correlations. Polynomial kernels only map data into a finite di-
mensional space. In addition, both linear and polynomial kernels are unbounded. Many radial basis
function kernels, such as the Gaussian kernel, map input data into an infinite dimensional space.
The Gaussian kernel has a free parameter (bandwidth) but follows a number of properties (e.g.,
boundedness, consistency, universality, and robustness).
In this study, while we applied the median of the pairwise distance as a bandwidth for the Gaus-
sian kernel, future studies might also compare the higher order interaction effects using a number of
different kernels with different parameters, which may have broad implications to the detection of
higher order interactions between disease phenotypes as described in the methods of this paper.
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Appendix
In the following sections, we present the details of the proposed method, Satterthwaite approxima-
tion to the score test, in addition we present supplementary tables and figures on our methods to
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their application to imaging genetics and epigenetics.
A Estimation of the linear mixed effect model using ReML
As discussed in the literature, we can estimate the variance components using the restricted max-
imum likelihood (ReML) approach (Harville, 1974; Lindstrom & Bates, 1988). The restricted
log-likelihood function of Eq. (13) is written as:
ℓR(θ) = −
1
2
ln(|Θ(θ)|) − 1
2
ln(|XTΘ−1(θ)X|) − 1
2
(y − Xβˆ)TΘ−1(θ)(y − Xβ) (A.1)
where βˆ is the BLUP of the regression coefficients β) Θ(θ) = σ2I+τ(1)K(1)+τ(2)K(2)+τ(3)K(3)+
τ(1×2)K(1×2)+τ(1×3)K(1×3)+τ(2×3)K(2×3)+τ(1×2×3)K(1×2×3), where θ = (σ2, τ(1), τ(2), τ(3), τ1×2, τ2×3, τ1×2×3)
are the variance components. To estimate the variance components, we need to perform the partial
derivative of Eq. (A.1) with respective to each variance component:
∂ℓR
∂θi
= −1
2
tr(WGi) +
1
2
(y − Xβˆ)TΘ−1(θ)GiΘ−1(θ)1T(y − Xβ)
= −1
2
tr (WGi) +
1
2
yTWGiWy = 0 (A.2)
where Gi =
∂Θ
θi
and W = Θ−1 − Θ−1X(XTΘ−1X)−1XTΘ−1. We also have ∂Θ
∂σ2
= I, ∂Θ
∂τ(1)
= K(1),
∂Θ
∂τ(2)
= K(2), ∂Θ
∂τ(3)
= K(3), ∂Θ
∂τ(1×2) = K
(1×2), ∂Θ
∂τ(1×3) = K
(1×3), ∂Θ
∂τ(1×2×3) = K
(1×2×3). The (i, j)-th
element of the observed and expected information matrices are
[
∂2ℓR
∂θi∂θ j
]
i j
= −1
2
tr(WGiWGj) + y
TWGiWGiWy,
E
[
∂2ℓR
∂θi∂θj
]
ij
= −1
2
tr(WGiWGj) = I(θ),
respectively. Using Fisher’s scoring algorithm (Newton-Raphson method to solve maximum like-
lihood equations numerically), given an initial value of unknown parameters at the h-th iteration
θ(k+1), the parameters are updated as
θ(k+1) = θ(k) + [I(θ−1(h)][
∂ℓR
∂θ
]θ(k) .
In expectation maximization (EM) algorithm, we used a set of initial points (0, 0.00001, 0.0001,
0.001, 0.01, 0.1, 1) of the variance components for the optimization algorithm and chose the best
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one (maximized ReML) to avoid the local minim (Laid, Lange, & Stram, 1987). For the σ2, we
fixed initial values to Var(y). After EM update, we then conducted the Fisher’s scoring algorithm
for the left iterations until the difference between successive log ReML values (|ℓR(h+1) − ℓR(h)|)
was smaller than 10−05. In most cases the ReML algorithm converged in less than 50 iterations
and in some cases it converged very quickly with 10 iterations, taking only a few seconds with an
R-program.
B Satterthwaite approximation to the score test
The restricted score function under the null hypothesis H0 : τ
(1) = τ(2) = τ(3) = τ(1×2) = τ(1×3) =
τ(2×3) = τ(1×2×3) = 0 is given by:
∂ℓR
∂θi
∣∣∣
τ=0
= − 1
2σ2
tr (W0Gi) +
1
2σ4
(y − Xβˆ)TΘ−1Gi(y − Xβ) (B.1)
where W0 = I − I(IT I)−1IT and τ = τ(1) = τ(2) = τ(3) = τ(1×2) = τ(1×3) = τ(2×3). Since the MLE
is
√
n consistent, the asymptotic distribution of S (σˆ2
0
) can still be approximated by the scaled chi-
square distribution. By considering the true value of σ2 under null hypothesis as σ2
0
, the mean and
variance of the test statistic S (σˆ2
0
) are:
E[S(σ20)] =
1
2
tr (W0K) = E[γχ
2
ν] = γν, and
Var[S(σ20)] =
1
2
tr (W0KW0K) = Var[γχ
2ν] = 2γ2ν
where K = K(1) + K(2) + K(3) + K(1×2) + K(1×3) + K(2×3) + K(1×2×3) and βˆ. To account for
this substitution, we need to estimate γ and ν by replacing the Var[S(σˆ2
0
)] based on the efficient
information. The elements of the Fisher information matrix τ are written as:
Iττ =

tr(A(1)A(1)) tr(A(1)A(2)) tr(A(1)A(3)) tr(A(1)A(1×2)) tr(A(1)A(1×3)) tr(A(1)A(2×3)) tr(A(1)A(1×2×3))
tr(A(2)A(1)) tr(A(2)A(2)) tr(A(2)A(3)) tr(A(2)A(1×2)) tr(A(2)A(1×3)) tr(A(2)A(2×3)) tr(A(2)A(1×2×3))
tr(A(3)A(1)) tr(A(3)A(2)) tr(A(3)A(3)) tr(A(3)A(1×2)) tr(A(3)A(1×3)) tr(A(3)A(2×3)) tr(A(3)A(1×2×3))
tr(A(1×2)A(1)) tr(A(1×2)A(2)) tr(A(1×2)A(3)) tr(A(1×2)A(1×2)) tr(A(1×2)A(1×3)) tr(A(1×2)A(2×3)) tr(A(1×2)A(1×2×3))
tr(A(1×3)A(1)) tr(A(1×3)A(2)) tr(A(1×3)A(3)) tr(A(1×3)A(1×2)) tr(A(1×3)A(1×3)) tr(A(1×3)A(2×3)) tr(A(1×3)A(1×2×3))
tr(A(2×3)A(1)) tr(A(2×3)A(2)) tr(A(2×3)A(3)) tr(A(2×3)A(1×2)) tr(A(2×3)A(1×3)) tr(A(2×3)A(2×3)) tr(A(2×3)A(1×2×3))
tr(A(1×2×3)A(1)) tr(A(1×2×3)A(2)) tr(A(1×2×3)A(3)) tr(A(1×2×3)A(1×2)) tr(A(1×2×3)A(1×3)) tr(A(1×2×3)A(2×3)) tr(A(1×2×3)A(1×2×3))

,
Iτσ2 =
1
2
[tr(A(1)) tr(A(2)) tr(A(1)) tr(A(1×2)) tr(A(1×3)) tr(A(2×3)) tr(A(1×2×3)],
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and Iσ2σ2 = 12 tr(W0W0), where A(1) = W0K(1), A(2) = W0K(2), A(3) = W0K(3), A(1×2) =
W0K
(1×2), A(1×3) = W0K(1×3), A(2×3) = W0K(2×3), A(1×2×3) = W0K(1×2×3). Using these infor-
mation matrices, we have the efficient information I˜ττ = Iτ,τ − ITτσ2I−1σ2σ2Iτσ2 and Var[S(σˆ20)] =
SUM[I˜ττ], where the operator ”SUM” indicates the sum of all the element in the matrix. By con-
sidering the adjusted parameters γˆ =
Var[S(σˆ2
0
)]
2E[S(σ2
0
)]
and νˆ =
2E[S(σ2
0
)2]
Var[S(σˆ2
0
)]
, the p−value of an experimental
score statistic S (σˆ2
0
) is obtained using the scaled chi-square distribution γˆχ2
νˆ
.
The score test statistic S I(τ˜I) defined in Eq. (16) for the higher order interaction effect that
testing the null hypothesis H0 : τ
(1×2×3) = 0 is approximated by a scaled chi-square distribution
γˆIχ
2
νˆI
. To do this, let Σ = σ2I+τ(1)K(1)+τ(2)K(2)+τ(3)K(3)+τ1×2K(1×2)+τ(1×3)K(1×3)+τ(2×3)K(2×3),
and τ(1), τ(2), τ(3), τ(1×2), τ(1×3), τ(2×3), and σ2 are model parameters under the null model y = Xβ +
hM(1) + hM(2) + hM(3) + hM(1)×M(2) + hM(1)×M(3) + ǫ. The score function Eq. (A.1) under the null
hypothesis becomes
∂ℓR
∂τ(1×2×3)
∣∣∣
τ(1×2×3)=0 = −
1
2σ2
[tr
(
W01K
(1×2×3)) − (y − Xβˆ)TΣ−1K(1×2×3)Σ−1(y − Xβ)]
= −1
2
[tr
(
W01K
(1×2×3)) − yTW01K(1×2×3)W01y) (B.2)
whereW01 = Σ
−1−Σ−1X(XTΣ−1X)−1XTΣ−1 is the projection matrix under the null hypothesis. The
test statistic for the higher order interaction effect is as follows:
S I(τI) =
1
2σ2
0
yTW01K
(1×2×3)W01y,
where τI = (τ
(1), τ(2), τ(3), τ(1×2)). Similarly for overall effect test, we can use the Satterthwaite
method to approximate the distribution of higher order intersection test statistic S I(τI) by a scaled
chi-square distribution with a scaled γI and degree of freedom νI, i.e., S I(τI) ∼ γIχ2νI . The mean and
variance of the test statistic S I(τI) are:
E[SI(τI)] =
1
2
tr
(
W01K
(1×2×3)) = E[γIχ2νI] = γIνI, and
Var[SI(τI)] =
1
2
tr
(
W0K
(1×2×3)W0K(1×2×3)
)
= Var[γIχ
2
νI
] = 2γ2I νI
whereK = K(1)+K(2)+K(3)+K(1×2)+K(1×3)+K(2×3)+K(1×2×3), γI =
Var[SI(τI]
2E[SI(τI]
and νI =
2E[SI(τI]
Var[SI(τI]
, re-
ceptively. In practice, the unknown model parameters τ(1), τ(2), τ(3), τ(1×2), τ(1×3), τ(2×3), and σ2 are
estimated by their respective ReML estimates τˆ(1), τˆ(2), τˆ(3), τˆ(1×2), τˆ(1×3), τˆ(2×3), and σˆ2 under the
null hypothesis. The scaled parameter and degree of freedom are estimated by the MOM. Specif-
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ically, γˆI =
̂Var[SI(τI)]
2 ̂E[SI(τI)] , and νˆI = 2
̂E[SI(τI)]̂Var[SI(τI)] , where ̂E[SI(τI)] = 12 tr
(
W01K
(1×2×3)) and ̂Var[SI(τI)] =
1
2
tr
(
W0K
(1×2×3)W0K(1×2×3)
)
− ∆ξ−1∆
2
, in which
∆ = [tr(B(1×2×3)W01) tr(B(1×2×3)B(1)) tr(B(1×2×3)B(2)) tr(B(1×2×3)B(3)) tr(B(1×2×3)B(1×2)) tr(B(1×2×3)B(1×3)) tr(B(1×2×3)B(2×3))]
ξ =

tr(W2
01
) tr(W01B
(1)) tr(W01B
(2)) tr(W01B
(3)) tr(W01B
(1×2)) tr(W01B(1×3)) tr(W01B(2×3))
tr(W01B
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Table 5: The selected significant genes-derived SNP, ROIs and gene-derived DNA methylation
using the proposed method (KMDHOI). The p−values threshold was fixed to 0.01.
KMDHOI
Genetics Imaging Epigenetics σ2 τ(1) τ(2) τ(3) τ1×2 τ1×3 τ2×3 τ1×2×3 OVA HOI
BDNF AMYG.L DUSP1 0.5658 0.0559 0.0887 0.0041 0.0494 2.1147 0.0000 0.0100 0.0345 0.0069
BDNF CRBL10.L FBXO28 0.5589 0.0334 0.1414 0.0157 1.2657 0.0000 0.2034 0.0100 0.0102 0.0058
BDNF CRBL3.R DUSP1 0.4255 0.2077 0.0000 0.0556 0.7339 2.1418 1.0345 0.0100 0.0414 0.0072
BDNF ORBsup.L FBXO28 0.5515 0.0033 0.4506 0.0535 0.8534 0.6955 0.0000 0.0100 0.0078 0.0013
BDNF LING.R CRABP1 0.5510 0.5258 0.2416 0.0640 0.9032 0.7442 0.0000 0.0100 0.0114 0.0074
BDNF IPL.R FBXO28 0.4471 0.0388 0.1458 0.0644 1.2503 2.3689 0.0000 1.9045 0.0367 0.0024
CHGA AMYG.L HOXA9 0.4326 0.0027 0.3130 0.3598 1.5185 0.0000 1.1948 0.7093 0.0474 0.0075
CHGB CRBL3.L DUSP1 0.6779 0.0321 0.1444 0.1232 0.2505 0.5545 0.0000 0.0100 0.0454 0.0025
CHGB DCG.L DUSP1 0.5253 0.0247 0.0213 0.0570 1.2794 1.0467 0.0000 0.0100 0.0408 0.0035
CHGB STG.L DUSP1 0.5415 0.1053 0.0360 0.0017 1.1720 1.2059 0.0000 0.0100 0.0293 0.0035
CLINT1 IPL.R GPSN2 0.4074 0.6728 0.0404 0.0514 1.2476 1.6953 0.0000 0.0100 0.0228 0.0042
COMTD1 ROL.R FBXO28 0.5717 0.0740 0.0095 0.0479 2.5561 0.3378 0.0000 2.3490 0.0370 0.0083
DAOA ORBsup.L DUSP1 0.3721 0.1079 0.0731 0.0097 0.5586 3.5344 0.0000 0.0100 0.0490 0.0012
DISC1 IPL.R PLAGL1 0.3370 0.0161 0.0547 0.1417 1.5286 3.2871 0.0000 1.4004 0.0439 0.0029
DRD2 ORBsup.R DUSP1 0.3772 0.0000 0.3189 0.0073 1.1268 2.0353 0.9757 0.0100 0.0445 0.0062
DTNBP1 IPL.R SRF 0.3940 0.1987 0.0637 0.2312 1.4537 1.8458 0.0000 0.0100 0.0267 0.0037
ERBB4 CRBLCrus2.R DUSP1 0.2576 0.0000 0.0413 0.0401 1.2244 3.1904 1.0830 0.0100 0.0459 0.0088
ERBB4 IPL.R FEN1 0.4484 0.0000 0.0762 0.0357 0.8799 2.9942 0.1061 0.0100 0.0294 0.0074
ERBB4 IPL.R HOXB4 0.3308 0.6704 0.0669 0.0222 2.3489 1.9820 0.0000 0.0100 0.0396 0.0082
GABBR1 LING.R CRABP1 0.5610 0.0068 0.4045 0.0563 1.8524 0.0000 0.7076 0.0100 0.0166 0.0072
GABRB2 SMA.R EDNRB 0.5276 0.0139 0.1276 0.0364 1.3359 2.4832 0.0000 2.0971 0.0283 0.0061
GRIN2B IPL.R HOXB4 0.3523 0.2359 0.0352 0.0297 2.1599 2.1357 0.0000 0.0100 0.0421 0.0012
GRM3 SMA.R EYA4 0.6435 0.0088 0.3928 0.0384 0.5390 1.5425 0.0000 0.4976 0.0237 0.0024
HTR2A ITG.L FBXO28 0.4496 0.3074 0.0087 0.0970 0.1874 2.0080 0.0000 0.0100 0.0211 0.0016
IL10RA LING.L CRABP1 0.5128 0.1846 0.1055 0.0436 1.3817 0.0000 0.1076 0.0100 0.0373 0.0035
IL10RA TPOsup.R CRABP1 0.5644 0.2024 0.0000 0.0364 1.3936 1.1762 0.0700 0.0100 0.0425 0.0098
IL1B AMYG.L FBXO28 0.5708 0.0130 0.4484 0.0755 1.8572 0.0000 0.3580 1.0757 0.0445 0.0040
IL1B CAU.R FBXO28 0.6755 0.0038 0.0229 0.1225 1.1013 0.0000 0.1307 1.3606 0.0383 0.0002
IL1B PoCG.R FBXO28 0.5837 0.0189 0.1827 0.1247 1.8403 0.0000 0.3469 1.0603 0.0202 0.0007
MAGI1 CRBL6.L CRABP1 0.3178 0.5873 0.0201 0.0249 1.7962 1.7014 0.0000 0.0100 0.0346 0.0045
MAGI2 CRBLCrus1.L FBXO28 0.1833 0.3246 0.0000 0.2693 1.1963 2.2426 1.3683 0.0100 0.0288 0.0000
MAGI2 DCG.R FBXO28 0.3211 0.0000 0.1485 0.0513 2.0150 2.5252 0.3083 0.0100 0.0298 0.0057
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Table 6: Table 5 continued:
KMDHOI
Genetics Imaging Epigenetics σ2 τ(1) τ(2) τ(3) τ1×2 τ1×3 τ2×3 τ1×2×3 OVA HOI
MAGI2 LING.L CRABP1 0.1813 0.4366 0.0000 0.0885 1.5370 2.6299 1.0271 0.0100 0.0470 0.0000
MAGI2 IPL.R SRF 0.2510 0.2349 0.0325 0.2015 1.4611 3.1453 0.0000 0.0100 0.0198 0.0087
MAGI2 IPL.L FBXO28 0.1833 0.3778 0.0000 0.3044 0.9808 2.3888 1.2203 0.0100 0.0457 0.0000
MICB Vermis3 FBXO28 0.6579 0.0806 0.0199 0.0444 0.0000 0.2964 0.4610 0.0100 0.0458 0.0060
NOS1AP IPL.R DUSP1 0.2939 0.0000 0.2870 0.3240 0.8961 1.8125 1.2330 0.0100 0.0185 0.0012
NOTCH4 Vermis3 FBXO28 0.7878 0.0000 0.0183 0.0896 0.3783 0.2783 0.0057 1.1039 0.0256 0.0054
NR4A2 PAL.R CRABP1 0.4953 0.1173 0.0000 0.0237 1.4544 0.3867 0.7814 0.0100 0.0491 0.0078
NRG1 IPL.R PLAGL1 0.3682 0.0024 0.2162 0.1270 1.1227 2.7930 0.0000 0.2056 0.0284 0.0000
NUMBL ORBsup.R CDKN1A 0.5418 0.0585 0.4680 0.0865 0.6606 0.4765 0.0000 0.0100 0.0479 0.0065
PDLIM5 ORBsup.R CCND2 0.4108 0.0109 0.4396 0.2792 0.0000 2.5753 0.2739 2.2025 0.0437 0.0016
PDLIM5 IPL.R DUSP1 0.3648 0.0000 0.0804 0.2182 1.5177 1.9409 1.0276 0.0100 0.0183 0.0005
PDLIM5 IPL.R PLAGL1 0.3134 0.0000 0.2173 0.2447 1.5550 1.8347 1.5020 0.0100 0.0460 0.0027
PDLIM5 PoCG.R DUSP1 0.3598 0.0000 0.2256 0.0139 0.9189 1.7853 1.2796 0.0100 0.0498 0.0004
PLXNA2 SMA.R RB1 0.2386 0.2186 0.2257 0.0341 0.8229 3.2966 0.0000 0.0100 0.0432 0.0017
PPP3CC IPL.R FBXO28 0.7594 0.0000 0.1627 0.0338 0.8919 0.5701 0.6865 0.0100 0.0199 0.0012
SLC18A1 ORBsup.R FHIT 0.4096 0.0065 0.5356 0.2276 1.3456 0.0000 1.0003 0.1323 0.0495 0.0001
SLC18A1 ORBsup.R PLAGL1 0.2869 0.0000 0.3909 0.1933 1.0186 1.3148 1.3676 0.0100 0.0373 0.0003
SLC18A1 Vermis45 TFPI2 0.5571 0.0447 0.0815 0.0020 0.0000 1.0458 0.5579 0.0100 0.0354 0.0007
SNAP29 ORBsup.R DUSP1 0.5384 0.0333 0.3235 0.0685 0.2128 1.3135 0.0000 0.0100 0.0417 0.0039
TDRD3 CRBL10.R EDNRB 0.5890 0.3319 0.0000 0.0310 0.9546 0.5359 0.8984 0.0100 0.0236 0.0025
TDRD3 CRBL3.L EYA4 0.5162 0.1651 0.1782 0.0612 0.4628 0.4991 0.0000 0.0100 0.0180 0.0019
TDRD3 CRBL45.L CCND2 0.5346 0.0523 0.2672 0.1649 0.3055 1.1277 0.0000 0.0100 0.0124 0.0019
TDRD3 CRBL8.L FBXO28 0.5856 0.2284 0.0022 0.0702 1.1722 0.7667 0.0000 0.0100 0.0052 0.0000
TDRD3 CRBL8.L ZNF512 0.5627 0.2690 0.0000 0.0375 0.7126 0.7087 1.3420 0.0101 0.0196 0.0021
TDRD3 CRBLCrus1.L WDR37 0.5287 0.1848 0.0563 0.0201 1.4667 0.6084 0.0000 0.0100 0.0423 0.0076
TDRD3 CRBLCrus2.L DUSP1 0.4862 0.2265 0.3120 0.0235 0.0000 1.2779 0.6463 0.0100 0.0185 0.0047
TDRD3 DCG.R EYA4 0.5874 0.1843 0.3626 0.0010 0.5656 0.1007 0.0000 0.0100 0.0135 0.0028
TDRD3 PCG.R DUSP1 0.8170 0.1434 0.0746 0.0690 0.0000 0.3873 0.0623 0.0100 0.0082 0.0079
TDRD3 PCG.R PTGS2 0.8223 0.1481 0.1251 0.0182 0.1414 0.5447 0.0000 0.0100 0.0256 0.0040
TDRD3 ORBsup.L FBXO28 0.5762 0.1398 0.3331 0.0679 0.8560 0.4102 0.0000 0.0100 0.0014 0.0050
TDRD3 ORBmid.R HOXA9 0.7235 0.3465 0.0000 0.2839 0.8353 0.5320 0.1433 0.0100 0.0067 0.0073
TDRD3 LING.L ZNF512 0.6416 0.0308 0.0000 0.1771 1.4260 0.3854 0.0717 0.0100 0.0312 0.0098
TDRD3 CAU.R CCND2 0.6381 0.1076 0.0170 0.0635 0.7395 1.2557 0.0000 0.0100 0.0096 0.0021
TDRD3 IPL.L ZNF512 0.6093 0.2597 0.0520 0.0380 1.0761 0.9126 0.0000 0.0100 0.0180 0.0018
TDRD3 TPOsup.L PLAGL1 0.6437 0.1242 0.0000 0.1318 0.0209 0.8248 0.3640 1.6934 0.0374 0.0024
TDRD3 MTG.R CCND2 0.2905 0.3650 0.0000 0.5177 0.8603 1.2746 1.6902 0.0100 0.0334 0.0040
TDRD3 ITG.R CRABP1 0.5291 0.2318 0.0000 0.0223 0.7052 0.6038 0.6240 0.0100 0.0033 0.0004
TDRD3 ITG.R EDNRB 0.4778 0.3792 0.0000 0.0265 1.0527 1.1174 0.9571 0.0100 0.0243 0.0085
TDRD3 Vermis10 FEN1 0.3894 0.5985 0.0000 0.0103 0.7989 1.4191 0.9878 0.0100 0.0377 0.0037
TDRD3 Vermis45 PTGS2 0.7504 0.1816 0.0718 0.0085 0.0000 0.4176 0.3236 0.0100 0.0121 0.0073
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Table 7: A part of 31 genes-derived SNP annotation using DAVID software.
Annotation Database Term No. genes P-Value Benjamini
Literature Pubmed-ID 19367581 12 1.6E − 22 5.8E − 19
18198266 7 3.0E − 15 5.5E − 12
19328558 8 1.1E − 13 1.4E − 10
19086053 11 5.3E − 13 4.9E − 102
12477932 31 4.4E − 6 1.8E − 3
15489334 21 5.5E − 5 .3E − 2
Disease GADB-disease-class Schizophrenia 26 1.1E − 26 4.4E − 24
Cognitive function 6 4.4E − 6 8.9E − 4
Bipolar disorder 6 1.5E − 3 9.8E − 2
Gene-Ontology GOTERM-BP-1 multicellular organismal process 17 1.3E − 4 2.4E − 3
Developmental process 13 1.7E − 3 2.4E − 3
Pathways KEGG Neuroactive ligand − receptor interaction 6 2.0E − 3 6.6E − 2
PANTHER P05912 4 7.8E − 3 2.6E − 1
P00001 3 9.0E − 3 1.6E − 1
Protein Interactions UCSC HFH3 22 2.5E − 5 4.4E − 3
BRN2 24 4.8E − 5 4.2E − 3
CDP 24 1.6E − 3 9.0E − 3
GATA 20 1.8E − 3 9.2E − 3
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